Table 1.

Summary of included studies (n = 19) on inotrope/vasopressor therapy in cardiogenic shock.

Study	Year	Country	Center	Setting	Inclusion Period	Follow-up	Overall N	CS N
Cronin	1965	Canada	Single	Retrospective cohort	1952–1961	10 years	140	140
Moulopoulos	1993	Greece	Single	Retrospective cohort	1978–1991	1 month	55	55
Andriange	1971	Belgium	Single	Retrospective cohort	1967–1970	1 year	450	45
Samimi-Fard	2007	Spain	Single	Randomized trial	2003–2004	1 year	22	22
El Mokhtari	2007	Germany	Single	Retrospective cohort	-	1 year	20	20
Fuhrmann	2008	Germany	Single	Randomized trial	2003–2005	30 days	32	32
Myburgh	2008	Australia	Multi	Randomized trial	2004–2006	90 days	280	128
Christoph	2008	Germany	Single	Prospective cohort	2003–2005	-	22	22
De Backer	2010	Belgium	Multi	Randomized trial	2003–2007	1 year	1679	280
Omerovic	2010	Sweden	Single	Prospective cohort	2004–2006	1 year	94	94
Caetano	2012	Portugal	-	Retrospective cohort (conference paper)	-	10.6 ± 10.9 months	37	37
Huseby	2013	Norway	Single	Randomized trial	2006–2010	6 months	61	9
Affronti	2013	Italy	Single	Retrospective case-control	2011	-	17	17
Katsytadze	2013	Ukraine	-	Retrospective cohort (conference paper)	-	1 year	27	27
Yagi	2015	Japan	Multi	Prospective cohort (conference paper)	2012–2014	30 days	979	240
Tarvasmaki	2016	Finland	Multi	Prospective cohort	2010–2012	90 days	216	216
Levy	2018	France	Multi	Randomized trial	2011–2016	60 days	57	57
Vally	2019	France	Single	Retrospective cohort	2010–2017	30 days	150	150
Lewis	2018	USA	Single	Retrospective cohort	2013–2015	In-hospital	100	100

CS: cardiogenic shock.